These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 15247495)

  • 21. Effect of quercetin and resveratrol co-incorporated in liposomes against inflammatory/oxidative response associated with skin cancer.
    Caddeo C; Nacher A; Vassallo A; Armentano MF; Pons R; Fernàndez-Busquets X; Carbone C; Valenti D; Fadda AM; Manconi M
    Int J Pharm; 2016 Nov; 513(1-2):153-163. PubMed ID: 27609664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The new materials technology of drug delivery.
    Williams D
    Med Device Technol; 2001 Oct; 12(8):10-3. PubMed ID: 12938542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of enzymatic free radical scavengers in management of oxidative stress in autoimmune disorders.
    Srivastava S; Singh D; Patel S; Singh MR
    Int J Biol Macromol; 2017 Aug; 101():502-517. PubMed ID: 28342757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thermolabile liposomes: a controlled release delivery tool in diagnosis/therapy in experimental pulmonary ɶdema.
    Santos AC; Matos CM; Oliveiros B; Almeida T; Gano L; Neves M; Ferreira N
    Curr Radiopharm; 2012 Apr; 5(2):166-74. PubMed ID: 22280109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.
    Rudokas M; Najlah M; Alhnan MA; Elhissi A
    Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):60-72. PubMed ID: 26938856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.
    Ahsan F; Rivas IP; Khan MA; Torres Suarez AI
    J Control Release; 2002 Feb; 79(1-3):29-40. PubMed ID: 11853916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery.
    Bhavane R; Karathanasis E; Annapragada AV
    J Control Release; 2003 Nov; 93(1):15-28. PubMed ID: 14602418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanocarriers for vascular delivery of antioxidants.
    Hood E; Simone E; Wattamwar P; Dziubla T; Muzykantov V
    Nanomedicine (Lond); 2011 Sep; 6(7):1257-72. PubMed ID: 21929460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nano-antioxidants: An emerging strategy for intervention against neurodegenerative conditions.
    Sandhir R; Yadav A; Sunkaria A; Singhal N
    Neurochem Int; 2015 Oct; 89():209-26. PubMed ID: 26315960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimuli-responsive Smart Liposomes in Cancer Targeting.
    Jain A; Jain SK
    Curr Drug Targets; 2018 Feb; 19(3):259-270. PubMed ID: 26853324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review.
    Xu Y; Liu H; Song L
    J Nanobiotechnology; 2020 Oct; 18(1):145. PubMed ID: 33076918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of phorbol myristate acetate-induced acute lung injury by alpha-tocopherol liposomes.
    Suntres ZE; Shek PN
    J Drug Target; 1995; 3(3):201-8. PubMed ID: 8705253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhalable liposomes for treating lung diseases: clinical development and challenges.
    Ponkshe P; Feng S; Tan C
    Biomed Mater; 2021 Jul; 16(5):. PubMed ID: 34134097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New concepts to fight oxidative stress: nanosized three-dimensional supramolecular antioxidant assemblies.
    Richard PU; Duskey JT; Stolarov S; Spulber M; Palivan CG
    Expert Opin Drug Deliv; 2015; 12(9):1527-45. PubMed ID: 25882382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds.
    Hu Y; Hollinger JO; Marra KG
    J Drug Target; 2001; 9(6):431-8. PubMed ID: 11822815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antioxidant activity of quercetin in Eudragit-coated liposomes for intestinal delivery.
    Caddeo C; Gabriele M; Fernàndez-Busquets X; Valenti D; Fadda AM; Pucci L; Manconi M
    Int J Pharm; 2019 Jun; 565():64-69. PubMed ID: 31071415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs.
    Fouladi F; Steffen KJ; Mallik S
    Bioconjug Chem; 2017 Apr; 28(4):857-868. PubMed ID: 28201868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.
    Babizhayev MA; Kasus-Jacobi A
    Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: An emerging need for novel drug delivery systems.
    Dua K; Malyla V; Singhvi G; Wadhwa R; Krishna RV; Shukla SD; Shastri MD; Chellappan DK; Maurya PK; Satija S; Mehta M; Gulati M; Hansbro N; Collet T; Awasthi R; Gupta G; Hsu A; Hansbro PM
    Chem Biol Interact; 2019 Feb; 299():168-178. PubMed ID: 30553721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.